Serina Therapeutics (SER) Q1 2024 Earnings
SER·Reported May 14, 2024·Before market open
Serina Therapeutics reported Q1 2024 revenue of $5.0K. Diluted EPS came in at $-3.38.
Revenue
$5.0K
Diluted EPS
$-3.38
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Serina Therapeutics's Q1 2024 earnings report.
Serina Therapeutics (SER) reported Q1 2024 earnings on May 14, 2024 before market open.
Serina Therapeutics reported revenue of $5.0K and diluted EPS of $-3.38 for Q1 2024.
You can read the 10-Q periodic report (0001493152-24-019248) directly on SEC EDGAR. The filing index links above go to sec.gov.